X
MET icon

Xponance’s MetLife MET Stock Holding History

Xponance’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3M Sell
215,705
-9,012
-4% -$727K 0.11% 137
2026
Q1 		$15.9M Buy
224,717
+92,886
+70% +$6.95M 0.11% 148
2025
Q4 		$10.4M Buy
131,831
+3,760
+3% +$298K 0.08% 197
2025
Q3 		$10.5M Buy
128,071
+4,672
+4% +$368K 0.08% 189
2025
Q2 		$9.92M Buy
123,399
+32,157
+35% +$2.48M 0.08% 190
2025
Q1 		$7.33M Sell
91,242
-28,525
-24% -$2.37M 0.07% 227
2024
Q4 		$9.81M Buy
119,767
+6,985
+6% +$581K 0.09% 175
2024
Q3 		$9.3M Buy
112,782
+28,159
+33% +$2.1M 0.09% 176
2024
Q2 		$5.94M Sell
84,623
-4,631
-5% -$331K 0.06% 253
2024
Q1 		$6.61M Buy
89,254
+5,447
+6% +$380K 0.07% 237
2023
Q4 		$5.54M Buy
83,807
+2,022
+2% +$127K 0.07% 239
2023
Q3 		$5.15M Sell
81,785
-7,025
-8% -$438K 0.07% 237
2023
Q2 		$5.02M Sell
88,810
-841
-0.9% -$46.7K 0.07% 247
2023
Q1 		$5.19M Buy
89,651
+1,525
+2% +$103K 0.08% 241
2022
Q4 		$6.38M Sell
88,126
-8,508
-9% -$609K 0.1% 189
2022
Q3 		$5.87M Buy
96,634
+6,305
+7% +$403K 0.11% 162
2022
Q2 		$5.67M Sell
90,329
-21,150
-19% -$1.4M 0.11% 156
2022
Q1 		$7.83M Buy
111,479
+2,076
+2% +$140K 0.13% 134
2021
Q4 		$6.84M Sell
109,403
-22,893
-17% -$1.44M 0.11% 169
2021
Q3 		$8.17M Sell
132,296
-5,138
-4% -$309K 0.16% 118
2021
Q2 		$8.22M Sell
137,434
-24,331
-15% -$1.54M 0.15% 119
2021
Q1 		$9.83M Sell
161,765
-139
-0.1% -$7.67K 0.21% 93
2020
Q4 		$7.6M Sell
161,904
-3,597
-2% -$156K 0.17% 110
2020
Q3 		$6.15M Sell
165,501
-29,908
-15% -$1.14M 0.15% 121
2020
Q2 		$7.14M Buy
+195,409
New +$6.8M 0.18% 112

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Xponance's MET Position: Q2 2026 in Review

Xponance reduced its MetLife (MET) stake by 4% in Q2 2026, selling an estimated $727K and leaving 215,705 shares worth $18.3M. The position accounts for 0.11% of the portfolio, ranked #137.

Xponance first reported a position in MET in Q2 2020 and has held it in 25 quarters since. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Xponance held 215,705 shares of MetLife worth $18.3M as of Q2 2026.
  • Xponance sold 9,012 MetLife shares in Q2 2026, an estimated $727K.
  • MetLife made up 0.11% of Xponance's portfolio in Q2 2026, its #137 holding.
  • Xponance first reported a position in MetLife in Q2 2020 and has held it in 25 quarters since.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.